| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LEAP THERAPEUTICS, INC. | Chief Scientific Officer | Common Stock | 15,896 | $5,033 | $0.3166 | 28 Mar 2025 | Direct |
| LEAP THERAPEUTICS, INC. | Chief Scientific Officer | Restricted Stock Units | 0 | $0 | $0.3166 | 28 Mar 2025 | Direct |
| LEAP THERAPEUTICS, INC. | Chief Scientific Officer | Employee Stock Option (Right to Buy) | 85,000 | 02 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LPTX | LEAP THERAPEUTICS, INC. | 30 Jun 2025 | 0 | $0 | 4 | Chief Scientific Officer | 01 Jul 2025, 16:31 |
| LPTX | LEAP THERAPEUTICS, INC. | 28 Mar 2025 | 3 | -$2,091 | 4 | Chief Scientific Officer | 01 Apr 2025, 21:53 |
| LPTX | LEAP THERAPEUTICS, INC. | 02 Oct 2024 | 1 | $0 | 4 | Chief Scientific Officer | 04 Oct 2024, 17:23 |
| LPTX | LEAP THERAPEUTICS, INC. | 29 Jan 2024 | 1 | $0 | 4 | Chief Scientific Officer | 31 Jan 2024, 21:35 |
| LPTX | LEAP THERAPEUTICS, INC. | 23 Aug 2023 | 1 | $0 | 4 | Chief Scientific Officer | 25 Aug 2023, 16:30 |
| LPTX | LEAP THERAPEUTICS, INC. | 01 Apr 2023 | 0 | $0 | 3 | Chief Scientific Officer | 03 Apr 2023, 19:49 |